Table 2

Expression of COX-1 in intrahepatic cholangiocarcinoma and matched non-tumorous tissue

Matched non-tumorous tissue
Case NoDifferentiation2-150Cholangiocarcinoma cellsBile duct cellsHepatocytes
Ratio of positive cells2-151IPRatio of positive cellsIPRatio of positive cellsIP
8Well0nanana0
9Well0031D
10Well0nananananana
11Well12F00
12Well0nananananana
13Well00nanana
14Well000
15Moderate0031D
16Moderate22Dnanana31D
17Moderate12Fnananananana
18Moderate12S031D
19Moderate0031D
20Moderate0021D
21Moderate12S00
22Moderate12F031D
23Moderate12Fnananananana
24Moderate0031D
25Poor000
26Poor31D031D
27Poor0031D
28Poor00nanana
29Poor22Dnanana12F
30Poor11S00
31Poor22D22Fnanana
  • I, intensity; P, pattern; D, diffuse; F, focal; S, sporadic; na, not available.

  • 2-150 Well differentiated cholangiocarcinoma: tumour cells are arranged to form well developed gland-like structures mainly lined by a single layer of epithelial cells with regular size and space and uniform nuclei with indistinct nucleoli; moderately differentiated cholangiocarcinoma: tumour cells are organised to form less well formed glandular structures which are often lined by stratified layers of epithelial cells with a higher degree of nuclear atypia; poorly differentiated cholangiocarcinoma: tumour cells rarely form glandular structures and their nuclei are arranged with an irregular spacing pattern and with markedly pleomorphic shapes and sizes. Tumour cells possess prominent nucleoli.

  • 2-151 For definition see table 1.

  • −, no immunosignal.